Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kiera Heffernan"'
Autor:
Scott Goulden, Kiera Heffernan, Fulya Sen Nikitas, Urmi Shukla, Craig Knott, Matthias Hunger, Ankit Pahwa, Rene Schade
Publikováno v:
Journal of Clinical Oncology. 40:e17534-e17534
e17534 Background: Limited tx options exist for pts with A/R EC who progress on/after platinum-based chemotherapy (PBCT). This study compared survival outcomes of pts with A/R mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3537bf5d537b6c3b813d673d89dd3be
https://doi.org/10.1200/jco.2022.40.16_suppl.e17534
https://doi.org/10.1200/jco.2022.40.16_suppl.e17534
Autor:
Charlie Gourley, Nichola Roebuck, Kiera Heffernan, Robert L Hollis, Zsofia Kiss, Helen Starkie-Camejo
Publikováno v:
Ovarian cancer.
Introduction/Background Niraparib is an oral, highly selective poly(ADP-ribose) polymerase inhibitor (PARPi). The PRIMA/ENGOT-OV26/GOG-3012 trial intention-to-treat population included stage III and IV ovarian cancer (OC) patients post-primary or int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39863de781e52f924137e9bb02416bc7
https://doi.org/10.1136/ijgc-2020-esgo.126
https://doi.org/10.1136/ijgc-2020-esgo.126
